Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPO in Traumatic Optic Neuropathy
NCT01783847Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2015
- Primary completion
- Apr 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of erythropoietin in traumatic optic neuropathy (TON), sponsored by Tehran University of Medical Sciences. Started Feb 2015; status: completed.
02
Drugs
erythropoietin
03
Conditions
traumatic optic neuropathy (TON)
Beyond the preview
Go deeper on NCT01783847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01783847.